BioSpace News Archive

CENTOGENE’s Lysosomal Storage Disorders Research to be Presented at the 14th Annual WORLDSymposium

The conference, which is being held February 5-9, 2018 in San Diego, CA, presents the latest information from basic science, translational research and clinical trials for lysosomal diseases.

February 1, 2018

·

1 min read

BIOTRONIK Release: CASTLE-AF Results Published in the New England Journal of Medicine, Showing Mortality Reduction for Heart Failure Patients

This reduction was observed when compared to patients treated with the pharmacological therapy recommended by current guidelines.

February 1, 2018

·

2 min read

Acerus Pharma’s NATESTO to Be Listed for Public Reimbursement in Quebec, Building on Strong 28% Increase in Natesto’s Canadian Prescriptions in Q4 2017

Acerus Pharma announced that it has received notice from Quebec’s National Institute for Excellence in Health and Social Services (INESSS) of a positive recommendation to the Health Minister for the inclusion of NATESTO® on the list of medications of the Régie de l’assurance maladie du Québec.

February 1, 2018

·

5 min read

Deals

Aviragen Provides New Information Supporting Vote FOR Vaxart Merger

The voting period will close at the upcoming Special Meeting of Stockholders on February 6, 2018.

February 1, 2018

·

11 min read

Lone Star Bio

Nuvectra Announces Proposed Follow-On Stock Offering

Nuvectra intends to use the net proceeds from this offering to fund the expansion of product development and commercialization activities, as well as for general corporate purposes.

February 1, 2018

·

6 min read

TVA Medical Release: Meta-Analysis Demonstrates Positive Clinical Experience Using everlinQ™ endoAVF System for Hemodialysis Acces

An international meta-analysis of clinical experience in patients who received an endoAVF for hemodialysis access was presented today at LINC 2018.

February 1, 2018

·

4 min read

Drug Development

Vical and Mycoses Study Group Education and Research Consortium Establish Collaboration to Advance Vical’s Novel Antifungal VL-2397 for the Treatment of Invasive Aspergillosis

This collaboration will combine the clinical development expertise of Vical with the specialized expertise of the MSGERC in the area of invasive fungal infections.

February 1, 2018

·

4 min read

Business

Abiomed Announces Q3 FY 2018 Record Revenue of $154M, Up 34% Over Prior Year

Financial and operating highlights during the third quarter of fiscal 2018 include:

February 1, 2018

·

11 min read

Biotech Beach

Viking Announces Proposed Public Offering of Common Stock

Viking today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

February 1, 2018

·

5 min read

Business

Amgen Reports Fourth Quarter and Full Year 2017 Financial Results

For the fourth quarter, total revenues decreased 3 percent versus the fourth quarter of 2016 to $5.8 billion.

February 1, 2018

·

61 min read